---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-019905"
form_type: "8-K"
ticker: "VICP"
cik: "0001468639"
company_name: "Vicapsys Life Sciences, Inc."
filed_at: "2023-06-02T23:59:59+00:00"
generated_at: "2026-06-14T08:07:58.641088+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "high"
source: SEC EDGAR
---

# Vicapsys Life Sciences amends patent license with Massachusetts General Hospital, adding new patent rights

## Summary
- Ninth Amendment adds Patent Rights MGH 24644 (PCT/US2018/051950) to exclusive license.
- Company must submit a research and development plan for new patent rights within one year.
- Company pays $2,000 non-refundable license fee and reimburses $3,956 in patent costs by July 31, 2023.
- Amendment updates diligence requirements under Section 3.1 of the original 2013 agreement.

## SEC filing metadata
- accession: 0001493152-23-019905
- form_type: 8-K
- ticker: VICP
- cik: 0001468639
- company_name: Vicapsys Life Sciences, Inc.
- filed_at: 2023-06-02T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468639/000149315223019905/0001493152-23-019905-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468639/000149315223019905/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-019905
- JSON: https://secwatch.observer/filing/0001493152-23-019905.json
- Plain text: https://secwatch.observer/filing/0001493152-23-019905.txt

## Key facts
- Material Agreements
  Vicapsys Life Sciences, Inc. amended Ninth Amendment to the Exclusive Patent License Agreement with The General Hospital Corporation d/b/a Massachusetts General Hospital (effective 2023-03-31).
  - Action: amendment
  - Agreement: license
  - Counterparty: The General Hospital Corporation d/b/a Massachusetts General Hospital
  - Effective: 2023-03-31
  source text: On March 31, 2023, Vicapsys Life Sciences, Inc.(the “Company”) and The General Hospital Corporation d/b/a Massachusetts General Hospital (the “Hospital”) entered into a Ninth Amendment to the Exclusive Patent License Agreement (the “Ninth Amendment”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1468639/000149315223019905/0001493152-23-019905-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.